IL84189A0 - Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents - Google Patents
Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agentsInfo
- Publication number
- IL84189A0 IL84189A0 IL84189A IL8418987A IL84189A0 IL 84189 A0 IL84189 A0 IL 84189A0 IL 84189 A IL84189 A IL 84189A IL 8418987 A IL8418987 A IL 8418987A IL 84189 A0 IL84189 A0 IL 84189A0
- Authority
- IL
- Israel
- Prior art keywords
- inflammatory agents
- malignant
- tumor necrosis
- combinations
- necrosis factors
- Prior art date
Links
- 108060008682 Tumor Necrosis Factor Proteins 0.000 title abstract 2
- 102000003390 tumor necrosis factor Human genes 0.000 title abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 abstract 4
- 102100040247 Tumor necrosis factor Human genes 0.000 abstract 4
- 230000003211 malignant effect Effects 0.000 abstract 3
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000009036 growth inhibition Effects 0.000 abstract 1
- 229960001680 ibuprofen Drugs 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91985186A | 1986-10-16 | 1986-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL84189A0 true IL84189A0 (en) | 1988-03-31 |
Family
ID=25442745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL84189A IL84189A0 (en) | 1986-10-16 | 1987-10-16 | Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0287633B1 (fr) |
| JP (1) | JPH01500905A (fr) |
| AT (1) | ATE91237T1 (fr) |
| DE (1) | DE3786456T2 (fr) |
| IL (1) | IL84189A0 (fr) |
| WO (1) | WO1988002632A1 (fr) |
| ZA (1) | ZA877771B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
| DE3816169A1 (de) * | 1988-05-11 | 1989-11-23 | Boehringer Ingelheim Kg | Verwendung und mittel zur verminderung der nebenwirkungen von tnf |
| US20030225254A1 (en) | 1989-08-07 | 2003-12-04 | Rathjen Deborah Ann | Tumour necrosis factor binding ligands |
| JP3443119B2 (ja) | 1989-08-07 | 2003-09-02 | ペプテック リミテッド | 腫瘍壊死因子結合リガンド |
| US6042837A (en) * | 1989-09-20 | 2000-03-28 | Kalland; Terje | Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC) |
| US5728388A (en) | 1989-10-03 | 1998-03-17 | Terman; David S. | Method of cancer treatment |
| EP1129717B2 (fr) * | 1990-01-17 | 2013-03-06 | TERMAN, David S. | Utilisation des homologues des enterotoxines de Staphylococcus pour le traitement du cancer |
| GB9005856D0 (en) * | 1990-03-15 | 1990-05-09 | Geistlich Soehne Ag | Compositions |
| CA2103045A1 (fr) * | 1991-05-14 | 1992-11-15 | Robert J. Leonard | Traitement avec un medicament a liberation prolongee base sur la modification de la reaction inflammatoire locale |
| WO1997048391A2 (fr) * | 1996-06-21 | 1997-12-24 | Advanced Research And Technology Institute | Methodes et compositions a base de r-ibuprofene |
| RU2145854C1 (ru) * | 1998-09-15 | 2000-02-27 | Ленин Петр Алексеевич | Противоопухолевое средство |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4677064A (en) * | 1984-11-09 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| EP0271521A4 (fr) * | 1986-05-09 | 1989-11-14 | Sloan Kettering Inst Cancer | Compositions a base de lipopolysaccharides et de facteurs naturels dans la therapie antitumorale et procede de traitement. |
-
1987
- 1987-10-14 AT AT87907079T patent/ATE91237T1/de not_active IP Right Cessation
- 1987-10-14 WO PCT/US1987/002602 patent/WO1988002632A1/fr not_active Ceased
- 1987-10-14 EP EP87907079A patent/EP0287633B1/fr not_active Expired - Lifetime
- 1987-10-14 DE DE87907079T patent/DE3786456T2/de not_active Expired - Fee Related
- 1987-10-14 JP JP62506436A patent/JPH01500905A/ja active Pending
- 1987-10-15 ZA ZA877771A patent/ZA877771B/xx unknown
- 1987-10-16 IL IL84189A patent/IL84189A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0287633A1 (fr) | 1988-10-26 |
| DE3786456T2 (de) | 1994-02-03 |
| ATE91237T1 (de) | 1993-07-15 |
| JPH01500905A (ja) | 1989-03-30 |
| DE3786456D1 (de) | 1993-08-12 |
| ZA877771B (en) | 1988-09-28 |
| EP0287633B1 (fr) | 1993-07-07 |
| WO1988002632A1 (fr) | 1988-04-21 |
| EP0287633A4 (fr) | 1989-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT38125A (en) | Process for preparing lymphokines /cytotoxic factors/ and pharmaceutical compositions containing such active substance | |
| CA2214097A1 (fr) | Emploi de ketorolac pour le traitement d'epithelioma spinocellulaires de la cavite buccale ou de l'arriere gorge | |
| GEP20022784B (en) | Celecoxib Composition | |
| IE862554L (en) | Pharmaceutical compositions | |
| IL84189A0 (en) | Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents | |
| UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
| IT1252868B (it) | Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico | |
| PT1015413E (pt) | Compostos anticancerígenos | |
| ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
| NO974693L (no) | Farmasöytisk preparat inneholdende N-klorfenylkarbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr | |
| GB8805792D0 (en) | Medicaments | |
| GR3006815T3 (fr) | ||
| AU563762B2 (en) | S-adenosyl-l-methionine salts preparation | |
| IL99778A0 (en) | Compositions for the treatment of cell proliferation disorders | |
| DK0452598T3 (da) | Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer | |
| FR2500303B1 (fr) | ||
| IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
| CA2078544A1 (fr) | Methode et compositions pour le traitement de lesions | |
| ZA81927B (en) | Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds | |
| DE2966809D1 (en) | 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them | |
| IL70253A0 (en) | Nitrosourea derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3380165D1 (en) | Analgesic combinations | |
| SE8402199L (sv) | Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist | |
| IT1265342B1 (it) | Composizioni farmaceutiche a base di derivati della glicina | |
| CA2088671A1 (fr) | Utilisation d'inhibiteurs de proteinases dependant de l'ion ca2+ dans les preparations pharmaceutiues |